Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	18.11	22.21	18.80
Graham Fair Price	-42.46	120531.05	209475.51
PEG	1069.59	-0.03	< 0.005
Price/Book	3.95	0.26	0.25
Price/Cash Flow	78.75	13.26	7.42
Prices/Earnings	220.66	4.33	-1.35
Price/Sales	25.30	1.24	0.99
Price/FCF	78.75	13.26	7.42
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.71	0.48	0.49
Operating Margin	-14.43	0.07	0.08
ROA	-67.31	< 0.005	-0.02
ROE	-0.05	0.02	-67.58
ROIC	0.02	< 0.005	-56.20
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.13	-93.69
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.30	-0.28	-5.04
EPS QOQ	-4.84	1.33	-72.58
FCF QOQ	-0.16	-0.41	-152.20
Revenue QOQ	0.13	-0.16	23.93
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	94.92	115.20	21.36
Days Sales Outstanding (DSO)	87.69	96.56	10.12
Inventory Turnover	0.95	0.78	-17.60
Debt/Capitalization	0.34	0.35	0.49
Quick Ratio	0.70	0.73	4.57
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	204414.50	206583.94	1.06
Cash	59124.29	61266.46	3.62
Capex	-5398.49	-7759.71	-43.74
Free Cash Flow	6942.07	4079.73	-41.23
Revenue	51942.28	43547.13	-16.16
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.90	0.96	5.62
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	13.24	15.37	16.07
Naive Interpretation	Member

06 - Financial Health · Bad

Rating